13 December 2021 - In a new report to the government, TLV forecasts that the pharmaceutical companies will pay approximately SEK 2.7 billion in reimbursement for medicines covered by side agreements between companies and regions for the year 2021.
This is approximately SEK 124 million lower than the refund paid for 2020 and SEK 385 million lower than the refund from 2019.
The main reason for the reduction is that the refund for the pharmaceutical group TNF inhibitors decreases as a result of the side agreements for these drugs expiring in October in year.